Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Spexis AG - Registered Shares?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Spexis AG - Registered Shares market cap is $140.55M.
What is the 52-week high for Spexis AG - Registered Shares?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Spexis AG - Registered Shares 52 week high is $2.50 as of September 06, 2025.
What is the 52-week low for Spexis AG - Registered Shares?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Spexis AG - Registered Shares 52 week low is $2.50 as of September 06, 2025.
What is Spexis AG - Registered Shares stock price today?
Spexis AG - Registered Shares stock price today is $2.50.
What was Spexis AG - Registered Shares stock price yesterday?
Spexis AG - Registered Shares stock price yesterday was $8.20.
What is the PE ratio of Spexis AG - Registered Shares?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Spexis AG - Registered Shares’s P/E ratio is -9.32.
What is the Price-to-Book ratio of Spexis AG - Registered Shares?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Spexis AG - Registered Shares P/B ratio is 6.7850.
What is the 50-day moving average of Spexis AG - Registered Shares?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Spexis AG - Registered Shares 50-day moving average is $2.50.
